89364-92-1 Usage
General Description
(HYDROXYAMIDINO)-ACETIC ACID ETHYL ESTER is a chemical compound with the molecular formula C5H11N3O3. It is an ester derivative of hydroxyamidino-acetic acid and is frequently used in laboratory research and chemical synthesis. It is primarily utilized in organic synthesis and drug discovery processes. (HYDROXYAMIDINO)-ACETIC ACID ETHYL ESTER is known for its potential biological and pharmaceutical applications, and it is often used as a building block in the synthesis of various pharmacologically active compounds. Additionally, it has been studied for its potential anti-inflammatory and anti-fibrotic properties. Overall, (HYDROXYAMIDINO)-ACETIC ACID ETHYL ESTER is a versatile chemical compound with various potential applications in the field of chemistry and pharmacology.
Check Digit Verification of cas no
The CAS Registry Mumber 89364-92-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,3,6 and 4 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 89364-92:
(7*8)+(6*9)+(5*3)+(4*6)+(3*4)+(2*9)+(1*2)=181
181 % 10 = 1
So 89364-92-1 is a valid CAS Registry Number.
InChI:InChI=1/C5H10N2O3.ClH/c1-2-10-5(8)3-4(6)7-9;/h9H,2-3H2,1H3,(H2,6,7);1H
89364-92-1Relevant articles and documents
Indazole-oxadiazole derivative, medicinal composition containing derivative, and application of derivative in tumor prevention
-
Paragraph 0099; 0100; 0117; 0118, (2017/07/25)
The invention discloses an indazole-oxadiazole derivative with the structure represented by general formula a shown in the description, or a pharmaceutically acceptable salt or solvate thereof. In the formula, X is O or N, Y is N, Z is N or O, and all groups are as defined in the description. The invention also discloses a medicinal composition adopting the derivative as an active component, and a use of the derivative. Compounds synthesized in the invention have an HIF-1 inhibition effect, and most of the compounds have a substantial HIF-1 inhibition effect, have strong in-vivo and in-vitro anti-HIF-1 effect on human colorectal carcinoma cell strains (HCT116) and other tumor cell strains, and can be used for treating tumor diseases.
NEW COMPOUNDS
-
Page 170, (2010/02/06)
The present invention relates to new compounds of formula I, (I) a process for their preparation and new intermediates prepared therein, pharmaceutical formulations containing said compounds and to the use of said compounds in therapy.
